Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase 3 study compared the efficacy and tolerability of AMP-100 to current standards of care

Trial Profile

A phase 3 study compared the efficacy and tolerability of AMP-100 to current standards of care

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 06 Dec 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Chloroprocaine (Primary)
  • Indications Anaesthesia
  • Focus Therapeutic Use
  • Sponsors Sintetica
  • Most Recent Events

    • 22 Feb 2022 According to a Harrow Health media release, the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) filing for AMP-100, for ocular surface anesthesia and intraoperative pain management during ocular surgery. The FDA has assigned the application standard review and a Prescription Drug User Fee Act (PDUFA) target action date of October 16, 2022.
    • 10 Aug 2021 According to a Harrow Health media release, company expects to submit NDA to FDA for AMP-100 in the next few months.
    • 04 Aug 2021 New trial record
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top